These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24693592)

  • 1. [The telethon and the promises not kept by gene therapy].
    Nau JY
    Rev Med Suisse; 2013 Dec; 9(411):2402-3. PubMed ID: 24693592
    [No Abstract]   [Full Text] [Related]  

  • 2. [From the first french Telethon to the rare diseases act: the role of AFM].
    Tiennot-Herment L
    Arch Pediatr; 2010 Jun; 17(6):699. PubMed ID: 20654848
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rare diseases health plan: outcome and expectations].
    Tchernia G; Le Hénanff G; Kremp-Roussey O
    Arch Pediatr; 2010 Jun; 17(6):700-1. PubMed ID: 20654849
    [No Abstract]   [Full Text] [Related]  

  • 4. [Telethon--a bioethical crystallization].
    Nau JY
    Rev Med Suisse; 2007 Nov; 3(135):2756. PubMed ID: 18214235
    [No Abstract]   [Full Text] [Related]  

  • 5. [The French Myology Association Telethon--investments in innovative projects].
    Barrier G; Biard E
    Med Sci (Paris); 2015 Nov; 31 Spec No 3():50. PubMed ID: 26546936
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neuromuscular diseases are many but rare].
    Lindvall B
    Lakartidningen; 2013 Apr 10-16; 110(15):752-3. PubMed ID: 23662534
    [No Abstract]   [Full Text] [Related]  

  • 7. Advocates to bring rare disease philanthropy under one umbrella.
    Dolgin E
    Nat Med; 2010 Aug; 16(8):837. PubMed ID: 20689536
    [No Abstract]   [Full Text] [Related]  

  • 8. Fighting rare diseases: the model of the telethon research institutes in Italy.
    Ballabio A; Naldini L
    Hum Gene Ther; 2015 Apr; 26(4):183-5. PubMed ID: 25901396
    [No Abstract]   [Full Text] [Related]  

  • 9. [Together for patients with hereditary neuromuscular conditions].
    Arntzen KA; Lund I; Rasmussen M; Rønningen KE; Torp TI; Ørstavik K
    Tidsskr Nor Laegeforen; 2016 Aug; 136(14-15):1198-9. PubMed ID: 27554555
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gene therapy and rare diseases].
    Cohen-Haguenauer O
    Rev Med Interne; 2011 Dec; 32 Suppl 2():S210-2. PubMed ID: 22037347
    [No Abstract]   [Full Text] [Related]  

  • 11. Gene therapy of inherited diseases.
    Fischer A; Cavazzana-Calvo M
    Lancet; 2008 Jun; 371(9629):2044-7. PubMed ID: 18555917
    [No Abstract]   [Full Text] [Related]  

  • 12. Gene therapies need new development models.
    Mavilio F
    Nature; 2012 Oct; 490(7418):7. PubMed ID: 23038429
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ophthalmogenetics: Rare Diseases - A Challenge for Diagnostic and Treatment].
    Rudolph G
    Klin Monbl Augenheilkd; 2016 Mar; 232(3):242. PubMed ID: 27011027
    [No Abstract]   [Full Text] [Related]  

  • 14. MRC Centre Neuromuscular Biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwide.
    Reza M; Cox D; Phillips L; Johnson D; Manoharan V; Grieves M; Davis B; Roos A; Morgan J; Hanna MG; Muntoni F; Lochmüller H
    Neuromuscul Disord; 2017 Nov; 27(11):1054-1064. PubMed ID: 28864117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A patient and family perspective on gene therapy for rare diseases.
    Kent A; Oosterwijk C
    J Gene Med; 2007 Oct; 9(10):922-3. PubMed ID: 17880044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuromuscular Gene Therapy: Catching the Wave of Positive Early Studies Is Expected to Crest in Product Approvals.
    Byrne BJ
    Mol Ther; 2019 Oct; 27(10):1695-1696. PubMed ID: 31558355
    [No Abstract]   [Full Text] [Related]  

  • 17. Bumps in the Road for Commercial Gene Therapy for Rare Diseases.
    Ylä-Herttuala S
    Mol Ther; 2017 Oct; 25(10):2225. PubMed ID: 28939088
    [No Abstract]   [Full Text] [Related]  

  • 18. New therapies for neuromuscular diseases in 2018.
    Shah AM; Al-Chalabi A
    Lancet Neurol; 2019 Jan; 18(1):12-13. PubMed ID: 30563673
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuromuscular disease: new insights and avenues for therapy.
    Scotter EL; Shaw CE
    Lancet Neurol; 2013 Jan; 12(1):13-5. PubMed ID: 23237893
    [No Abstract]   [Full Text] [Related]  

  • 20. The Treatabolome, an emerging concept.
    Bonne G
    J Neuromuscul Dis; 2021; 8(3):337-339. PubMed ID: 33935101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.